Cyclerion Therapeutics, Inc. Banner Image

Cyclerion Therapeutics, Inc.

  • Ticker CYCN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cyclerion Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Lead programs include its vascular-targeted olinciguat in Phase 2 development for sickle cell disease and IW-6463, a pioneering CNS-penetrant sGC stimulator in clinical development forMore Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer's Disease with Vascular pathology (ADv)
4.8 / 5.0 (120)

Cyclerion Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 120 reviews.

Cyclerion Therapeutics, Inc.

Most Recent Annual Report

Cyclerion Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Cyclerion Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!